Journal article · 2016 · Open access

Adaptive Licensing – Gefahr für Patienten?

Bernd Mühlbauer

Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen, 112, S34–S37 · Published 1 January 2016 · DOI 10.1016/j.zefq.2016.04.005

Open full textCite this paper

In brief

“Adaptive Licensing – Gefahr für Patienten?” is a 2016 journal article by Bernd Mühlbauer, published in Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. OpenAlex counts 4 citations as of 19 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen.

Citations
4
Most cited in
2016 (1)
Field-weighted impact
1.73
References
6
Authors
1

Abstract

In 2014, a pilot project of the European licensing authority EMA was launched to explore new ways to license medicinal products. The intention of this project is to open up gradual ("adaptive") licensing pathways, with pharmaceutical developing preparations gaining market authorization on the basis of clearly lower-level evidence of effectiveness and risk of damage than before. Their market authorization shall, initially, be restricted, for example, to subpopulations of patients or to selected indications. When new data from subsequent become available, the extension of the authorization shall follow in a stepwise manner. Data from investigations using less valid methodology shall also find consideration, such as, for example data from uncontrolled studies. The experience with accelerated market access, which is already being offered by several drug authorities, may give rise to concerns about the use of procedures that keep drugs with a negative benefit-risk relation for the patients in the market for many years - apart from the costs for the healthcare system. It is unacceptable that manufacturers will be exempt from (strict) liability for these adaptively licensed pharmaceuticals. If patients suffer damage from taking these medications, they cannot even expect material compensation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Mühlbauer, B. (2016). Adaptive Licensing – Gefahr für Patienten? Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen, 112, S34–S37. https://doi.org/10.1016/j.zefq.2016.04.005

MLA 9

Mühlbauer, Bernd. “Adaptive Licensing – Gefahr für Patienten?” Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen, vol. 112, 2016, pp. S34–S37. https://doi.org/10.1016/j.zefq.2016.04.005.

Chicago

Mühlbauer, Bernd. 2016. “Adaptive Licensing – Gefahr für Patienten?” Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen 112: S34–S37. https://doi.org/10.1016/j.zefq.2016.04.005.

Harvard

Mühlbauer, B. (2016) ‘Adaptive Licensing – Gefahr für Patienten?’, Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen, 112, pp. S34–S37. doi:10.1016/j.zefq.2016.04.005.

IEEE

B. Mühlbauer, “Adaptive Licensing – Gefahr für Patienten?,” Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen, vol. 112, pp. S34–S37, 2016, doi: 10.1016/j.zefq.2016.04.005.

BibTeX

@article{muhlbauer2016adaptive,
  title     = {{Adaptive Licensing – Gefahr für Patienten?}},
  author    = {Mühlbauer, Bernd},
  journal   = {Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen},
  year      = {2016},
  volume    = {112},
  pages     = {S34--S37},
  doi       = {10.1016/j.zefq.2016.04.005},
  url       = {https://doi.org/10.1016/j.zefq.2016.04.005}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201611
201711
201811
201911

Its field-weighted citation impact is 1.73: it has been cited 1.73 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation

  • European Medicines Agency
  • drug approval
  • risk-benefit assessment
  • uncontrolled studies
  • pharmaceutical liability
  • patient safety
  • regulatory science

Work with this paper

Most-cited papers in Nursing

All highly cited Nursing papers

Questions about this paper

How do I cite this paper in APA style?

Mühlbauer, B. (2016). Adaptive Licensing – Gefahr für Patienten? Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen, 112, S34–S37. https://doi.org/10.1016/j.zefq.2016.04.005

How many times has this paper been cited?

4 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen: sign in and open the full text from this page.

Who wrote this paper?

Bernd Mühlbauer.

What is the DOI of this paper?

10.1016/j.zefq.2016.04.005, permanently at https://doi.org/10.1016/j.zefq.2016.04.005. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.